Dispensing of Funded NSAIDs in General Population
Identifying Attributes
Care Settings
Primary Care
Country
New Zealand
Publishing Organisation
Health Quality & Safety Commission
Type of Quality Indicator
Process
IOM Quality Dimension
Effectiveness
Domain
Medications and Medication Management
Defining Attributes
Definition
The dispensing of funded NSAIDs in the rest of the New Zealand resident population, by DHB (percent)
Numerator
PHO-enrolled population aged 20 years and over who were dispensed NSAIDs, excluding those with identified gout.
Denominator
Statistics New Zealand population aged 20 and over, using 2019 projections.
Exclusions
None
Use of Risk Adjustment
No
Risk Adjustments
Stratifications
By year (2012-2019), age group (20-44, 45-64, 65+) and ethnicity (Māori, Pacific peoples, non-Māori, non-Pacific).
Collection and Reporting Attributes
Type of Data Collection
Standardised clinical data
Data Collection Methods
Ministry of Health: Pharmaceutical Collection and PHO enrolments (numerator). Stats NZ: population projection (denominator).
Frequency of Data Collection
Frequency of Data Collection in Days
Reporting Methods
Atlas of Healthcare Variation website
Reporting Frequency
Annually
Reporting Frequency in Days
365
Indicator Has Recommended Targets
No
Source and Reference Attributes
Technical Specifications
Link to Measurement Tools
Quality Indicator Confirmed to be Part of a Program Used to Monitor Quality and Safety of Care Among Older People at a Population-Level between 2012-2022
Yes
Assessed by the Australian Consortium for Aged Care Collaborators as Generally Containing Good Properties (Importance and Scientific Acceptability)
No
Australian Consortium for Aged Care Endorsed
No
Identified by PHARMA-Care Project
No
Upload Date
02 December 2025
Contents
Actions
Date Modified 02 December 2025